SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Charges
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Deferred Charges of -$141.00 thousand for the 6-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2025-11-04
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2021-03-31 was -$2.26M.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2020-12-31 was -$45.00K, a 164.29% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2020-09-30 was -$34.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for the quarter ending 2020-06-30 was -$31.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2023 was $102.00K, a 66.99% decline from fiscal 2022.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2022 was $309.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in deferred charges for fiscal 2021 was -$2.37M.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$141.00K 10-Q · filed 2025-11-04 | |||
| 2024-09-30 | -$188.00K 10-Q · filed 2025-11-04 | |||
| 2023-03-31 | $102.00K 10-K · filed 2023-06-21 | |||
| 2022-03-31 | $309.00K 10-K · filed 2022-07-13 | |||
| 2021-03-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | -$2.30M derived: sum of 2 quarters · filed 2021-07-14 | -$2.34M derived: sum of 3 quarters · filed 2021-07-14 | -$2.37M 10-K · filed 2021-07-14 |
| 2020-12-31 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | -$79.00K derived: sum of 2 quarters · filed 2021-02-16 | -$110.00K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$34.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$65.00K 10-Q · filed 2020-11-20 | ||
| 2020-06-30 | -$31.00K 10-Q/A · filed 2020-11-17 | |||
| 2019-12-31 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $35.00K derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | |
| 2019-09-30 | -$35.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$70.00K 10-Q · filed 2020-11-20 | ||
| 2019-06-30 | -$35.00K 10-Q/A · filed 2020-11-17 | |||
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |